UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000019510
Receipt No. R000022529
Official scientific title of the study The safety of therapeutic hypothermia for acute encephalitis / encephalopathy among pediatric patients
Date of disclosure of the study information 2015/10/27
Last modified on 2018/04/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The safety of therapeutic hypothermia for acute encephalitis / encephalopathy among pediatric patients
Title of the study (Brief title) The safety of therapeutic hypothermia for acute encephalitis / encephalopathy among pediatric patients
Region
Japan

Condition
Condition Acute encephalitis and encephalopathy among pediatric patients
Classification by specialty
Pediatrics Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate if therapeutic hypothermia could be done as safely for acute encephalitis / encephalopathy of pediatric patients as that for another conditions.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes If there occur any medical condition for which therapeutic hypothermia must be discontinued.
Key secondary outcomes If there are seen more labo data, clinical signs, or monitored signs, that represent complications such as coagulopathy, infection, or worsened general conditions.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment Maneuver
Interventions/Control_1 Therapeutic hypothermia (34 degree Celsius for 72 hours, followed by 48 hours of warming) using cooling pads.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
18 years-old >
Gender Male and Female
Key inclusion criteria Pediatric patients less than 18 years old, who are diagnosed as acute encephalitis / encephalopathy, with no improvement or progressive worsening.
Acute encephalitis / encephalopathy would be diagnosed,when any findings as below are seen with no improvement within 3 hours:
1) acutely and moderately worsened consciousness level with JCS (Japan Coma Scale) more than 20,
2) mildly worsened consciousness level with JCS more than 10 lasting more than 24 hours,
3) accompanied with abnormal findings on head CT or head MRI, or
4) accompanied with abnormal EEG findings
Key exclusion criteria Because coagulopathy are common during hypothermia,
(1-1) Intracranial hemorrhage was seen on head CT or MRI,
(1-2) Hemorrhagic diathesis, or
(1-3) thrombocytopenia less than 50,000/mm3.

Because immunosuppression are common during hypothermia,
(2-1) Congenital immunologic disability (SCID, a-gamma-globurinemia, chronic granulomatous disease, et.al).

Because circulation are easily suppressed during hypothermia,
(3-1) Cardiac disease or arrhythmia, which need medication.
(3-2) Decreased cardiac contractility (LVEF < 40% on echocardiogram)
(3-3) Normal blood pressure is not maintainable even with catecholamines or vasopressors.

Because this study needs informed consent from legal representatives,
(4-1) When legal representatives denied to be participated,
(4-2) When child abuse is strongly suspected,

Or whenever the regarding physicians thought the patient is not suitable for this study.
Target sample size 30

Research contact person
Name of lead principal investigator Atsushi Numaguchi
Organization Nagoya University Hospital
Division name Department of emergency and critical care medicine
Address 65 Tsurumai-Cho, Showa-Ku, Nagoya City
TEL 052-744-2659
Email nummer@med.nagoya-u.ac.jp

Public contact
Name of contact person Atsushi Numaguchi
Organization Nagoya University Hospital
Division name Department of Emergency and Critical Care Medicine
Address 65 Tsurumai-Cho, Showa-Ku, Nagoya City
TEL 052-744-2659
Homepage URL
Email nummer@med.nagoya-u.ac.jp

Sponsor
Institute Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 27 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 04 Month 01 Day
Anticipated trial start date
2015 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 10 Month 27 Day
Last modified on
2018 Year 04 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022529